Publication

Global Review of the Age Distribution of Rotavirus Disease in Children Aged < 5 Years Before the Introduction of Rotavirus Vaccination

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Mateusz Hasso-Agopsowicz, London School of Hygiene & Tropical MedicineChandresh Nanji Ladva, London School of Hygiene & Tropical MedicineBenjamin Lopman, Emory UniversityColin Sanderson, London School of Hygiene & Tropical MedicineAdam Cohen, Emory UniversityJacqueline E. Tate, London School of Hygiene & Tropical MedicineXimena Riveros, World Health OrganizationAna Maria Henao-Restrepo, World Health OrganizationAndrew Clark, London School of Hygiene & Tropical Medicine
Language
  • English
Date
  • 2019-09-15
Publisher
  • Oxford University Press
Publication Version
Copyright Statement
  • © 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 69
Issue
  • 6
Start Page
  • 1071
End Page
  • 1078
Grant/Funding Information
  • This work was supported by the Bill & Melinda Gates Foundation (BMGF), Grant Numbers OPP1147721 and OPP1163272. Support for this project was also provided by PATH, WHO and NIH (R01 AI112970).
Supplemental Material (URL)
Abstract
  • We sought datasets with granular age distributions of rotavirus-positive disease presentations among children <5 years of age, before the introduction of rotavirus vaccines. We identified 117 datasets and fit parametric age distributions to each country dataset and mortality stratum. We calculated the median age and the cumulative proportion of rotavirus gastroenteritis events expected to occur at ages between birth and 5.0 years. The median age of rotavirus-positive hospital admissions was 38 weeks (interquartile range [IQR], 25-58 weeks) in countries with very high child mortality and 65 weeks (IQR, 40-107 weeks) in countries with very low or low child mortality. In countries with very high child mortality, 69% of rotavirus-positive admissions in children <5 years of age were in the first year of life, with 3% by 10 weeks, 8% by 15 weeks, and 27% by 26 weeks. This information is critical for assessing the potential benefits of alternative rotavirus vaccination schedules in different countries and for monitoring program impact.
Author Notes
  • Correspondence: M. Hasso-Agopsowicz, Initiative for Vaccine Research (IVR), Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 20 Ave Appia, CH-1211 Geneva 27, Switzerland mateusz.hasso-agopsowicz@lshtm.ac.uk
Keywords
Research Categories
  • Biology, Microbiology
  • Health Sciences, Immunology

Tools

Relations

In Collection:

Items